Institutional 10... · Libbs Pharmaceutical RANK 2017 1 UNITED STATES 2 CHINA 3 JAPAN 4 BRAZIL 5 GERMANY 6 FRANCE 7 ITALY 8 RUSSIA 9 INDIA 10 CANADA 11 UK 12 SPAIN 13 AUSTRALIA 14

Biosimilar Products

in Brazil

Edilson Uiechi

Government Affairs

Libbs Pharmaceutical

RANK 2017

1 UNITED STATES

2 CHINA

3 JAPAN

4 BRAZIL

5 GERMANY

6 FRANCE

7 ITALY

8 RUSSIA

9 INDIA

10 CANADA

11 UK

12 SPAIN

13 AUSTRALIA

14 ARGENTINA

15 SOUTH KOREA

16 MEXICO

17 TURKEY

18 INDONESIA

19 VENEZUELA

20 POLAND

RANK

BRAZIL

10º 2007

6º 2012

4º 2017

Institutional

Farmacêutica

Unidade B2B (JAN-DEZ 2013)

Faturamento: R$ 271 mi

Farmacêutica

Unidade B2C (JAN-DEZ 2013)

Faturamento: R$ 777,3 mi

Farmoquímica (JAN-DEZ 2013)

Faturamento: R$ 50,6 mi

Business Units

Therapeutic specialties

Gynecological

Cardiovascular

NCS

Dermatology

Respiratory

Oncology

Transplants

other specialties

Global Quality - Active pharmaceutical

ingredients for Europe and Mercosul

Tibolone

Mazindol

Gestodeno

• Production

• 20 APIs

• R&D

Pathways for innovation

2005

2010

2013

“Innovation”

Marketing opportunities; small differences

Incremental innovation New associations, new in Brazil, technological barriers

Rupture New molecules, New therapies

Networking of development and

Innovation - Partnerships

USA

BRAZIL

LATIN AMERICA

EUROPE

SPAIN ASIA

Investiment em R,D&I

28,4 28,6 31,2 46 48,4

88,5

153,5*

0

20

40

60

80

100

120

140

160

180

2008 2009 2010 2011 2012 2013 2014

9,2 8,11 7,67

9,33

5,98

9,74

14*

0

2

4

6

8

10

12

14

16

2008 2009 2010 2011 2012 2013 2014

Investiment em R,D&I - R$ M % invoicing

*estImative

Investiment 2014-2017

MM R$

R$ 1,258 bi

4y

R&D

529 Biotec

378 Infra

351

Biotec Unit

• 400kg/ano of MABs

• Single use Technology

• First GMP Batch -2016 • FDA

• EMA

• ANVISA

Libbs industrial Complex

Biosimilars Tech Transfer

Patient Access

Biobetters

Inovators

WHY BIOSIMILAR FOR LIBBS?

Development and

Production

Synthetic Drugs

Development

and Production

Pharmaceutical Active

(API)

Technological

Knowledge Incorporation of

technology

Biobetters

&

Innovators National

strengthening of the

medicines

production

Biosimilar • Human resource

and knowledge

• Biological

Production

Networking of development and Innovation

Growing of Innovation Network and Partners

Worldwide

USA

BRAZIL

LATIN AMERICA

EUROPE

SPAIN ASIA

Edilson Uiechi Government Affairs Manager

[email protected]

Tel.: 55 (11) 3879 2500

www.libbs.com.br

THANK YOU!